Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1242, pseudogene (RNU6-1242P)
- Target
- RNU6-1242P
- Molecular classification
- Other (pseudogene), Small non-coding RNA-related pseudogene
01
Overview
RNU6-1242P is a processed pseudogene of the U6 small nuclear RNA (snRNA) family located on human chromosome 18. Pseudogenes arise primarily from retrotransposition events where RNA is reverse-transcribed and integrated into the genome, losing its function due to lack of regulatory elements or mutations. They do not encode functional RNA or protein and may act as evolutionary markers for genome organization or retrotransposition history. The U6 snRNA itself is an essential component of the spliceosome, but RNU6-1242P is a non-functional copy that serves no independent biological role.
- Other names
- RNU6-1242PRNA, U6 small nuclear 1242, pseudogeneHGNC:48205NCBI Gene: 106480108Ensembl: ENSG00000212354GC18M037259GC00U935342
02
Mechanism of action
None. As a pseudogene, there is no mechanism of action relevant for drug targeting or pharmacology
03
Biological functions
None (as a pseudogene, it does not produce functional products or participate in gene regulation or molecular pathways directly)
04
Disease associations
None specifically attributed; pseudogene formation is a marker of retrotransposition rather than a disease-associated function
05
Safety considerations
None.
06
Interacting drugs
None
07
Biomarkers
None for patient selection or efficacy monitoring.
Beyond the preview
Go deeper on RNA, U6 small nuclear 1242, pseudogene (RNU6-1242P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1242, pseudogene (RNU6-1242P).